A detailed history of Rothschild Investment LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 384 shares of PACB stock, worth $675. This represents 0.0% of its overall portfolio holdings.

Number of Shares
384
Previous 79 386.08%
Holding current value
$675
Previous $108,000 504.63%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$1.2 - $2.17 $366 - $661
305 Added 386.08%
384 $653,000
Q2 2024

Jul 30, 2024

BUY
$1.36 - $3.65 $107 - $288
79 New
79 $108,000
Q1 2024

Jul 31, 2024

BUY
$3.52 - $9.59 $123 - $335
35 Added 44.3%
114 $428,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $396M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.